Romergoline

Romergoline is a novel ergoline derivative with a distinctive dual pharmacological profile, acting as a full dopamine antagonist in intact systems and a full agonist in denervated models. This makes it a valuable research tool for studying dopamine receptor plasticity and neurodegeneration, applicable in both in vitro binding assays and in vivo animal studies of Parkinson's disease.